Curosurf

Company: Dey Laboratories
Approval Status: Approved October 1998
Treatment for: Pediatric Respiratory Distress Syndrome
Areas: Pediatrics; Respiratory

| General Information |

General Information

Curosurf is used as a treatment for respiratory distress syndrome in premature infants.

< back to top

Curosurf Drug Information

The Curosurf drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.